Project Description


Respinor is a Norwegian company, that have developed an ultrasound medical device, DXT.

DXT, or Diaphragm Excursion Technology, is a non-invasive medical device that utilizes ultrasound for continuous monitoring of the diaphragm, the main breathing muscle, in critically ill patients. This technology aids in the early detection of diaphragm dysfunction and enhances clinical decision-making in critical care settings. It aims to optimise extubation timing, reduce re-intubation rates, improve patient outcomes, and thereby lower healthcare costs.

DXT provides actionable output, to detect patients at increased risk of reintubation during the weaning process from MV.

Respinor joined NOME in 2023.

Company details


More companies